title: Implantation of a SAPIEN 3 Valve in a Patient with Pure Aortic Regurgitation.
abstract: Transcatheter aortic valve implantation (TAVI) is an emerging treatment for high-risk patients with aortic stenosis. Aortic regurgitation is considered to be a relative contraindication for transcatheter procedures, as a non-calcified aortic annulus poses the risk of an insufficient anchoring of the transcatheter aortic valve prosthesis. Herein is described the case of a patient who suffered from recurrent aortic valve regurgitation after valve-sparing repair, and which was successfully treated by the transcatheter implantation of an Edwards SAPIEN 3™ prosthesis. This case report demonstrated the suitability of this prosthesis to treat pure aortic valve regurgitation, without excessive oversizing of the valve.
authors.affiliation: Department of Cardiovascular Surgery, University Hospital, Düsseldorf, Germany. Electronic correspondence: phil.minol@gmx.de.
authors.forename: Jan-Philipp
authors.initials: JP
authors.lastname: Minol
authors.affiliation: Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany.
authors.forename: Verena
authors.initials: V
authors.lastname: Veulemans
authors.affiliation: Cardiology, Pulmonology and Angiology, University Hospital, Düsseldorf, Germany.
authors.forename: Tobias
authors.initials: T
authors.lastname: Zeus
authors.affiliation: Department of Cardiovascular Surgery, University Hospital, Düsseldorf, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Blehm
mesh_terms: D000328:Adult; D001022:Aortic Valve Insufficiency / Q000601:surgery*; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D012008:Recurrence; D012307:Risk Factors; D065467:Transcatheter Aortic Valve Replacement; D016896:Treatment Outcome